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Abstract: Neutrophils play an important role in implant-mediated inflammation and 
  infection. Unfortunately, current methods which monitor neutrophil activity, including enzyme 
  measurements and histological evaluation, require many animals and cannot be used to accurately 
depict the dynamic cellular responses. To understand the neutrophil interactions around 
implant-mediated inflammation and infection it is critical to develop methods which can monitor 
in vivo cellular activity in real time. In this study, formyl peptide receptor (FPR)-targeting near-
infrared nanoprobes were fabricated. This was accomplished by conjugating near-infrared dye 
with specific peptides having a high affinity to the FPRs present on activated neutrophils. The 
ability of FPR-targeting nanoprobes to detect and quantify activated neutrophils was assessed 
both in vitro and in vivo. As expected, FPR-targeting nanoprobes preferentially accumulated on 
activated neutrophils in vitro. Following transplantation, FPR-targeting nanoprobes preferen-
tially accumulated at the biomaterial implantation site. Equally important, a strong relationship 
was observed between the extent of fluorescence intensity in vivo and the number of recruited 
neutrophils at the implantation site. Furthermore, FPR-targeting nanoprobes may be used to 
detect and quantify the number of neutrophils responding to a catheter-associated infection. 
The results show that FPR-targeting nanoprobes may serve as a powerful tool to monitor and 
measure the extent of neutrophil responses to biomaterial implants in vivo.
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Introduction
The accumulation of neutrophils in tissue is a hallmark of the acute inflammatory 
response.1–3 Following biomaterial implantation, many circulating neutrophils and 
macrophages/monocytes migrate from the blood stream to the implant’s   surrounding 
tissue.4,5 Subsequent interactions and cellular activation initiates the acute foreign 
body response.2,3 Studies have shown that recruited neutrophils release a large amount 
of granular enzymes and reactive oxygen species, including hydrogen   peroxide and 
superoxide anions.6,7 Activated neutrophils and their products have also been shown 
to cause the degradation of polymeric implants and tissue engineering scaffolds.8,9 
Furthermore, it has been suggested that the accumulation of activated neutrophils 
around biomaterial implants may lead to increased fibrotic reactions, delayed 
  tissue regeneration, or even tissue damage.10,11 Moreover, the impaired bactericidal 
activities of implant-associated neutrophils are thought to be responsible for the 
pathogenesis of device-centered infection.12 Therefore, vast research efforts have 
been placed on studying the interactions between biomaterial implants and immune 
cell responses.
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It is well established that there is a good relationship 
between the number of recruited neutrophils and the extent of 
biomaterial-mediated inflammatory responses.4,5 The degree of   
the implant-associated neutrophil response may be quanti-
fied by either myeloperoxidase enzyme measurement4,5 or 
  histological staining.13,14 However, these methods have at least 
three   inherent disadvantages. First, to determine the kinetics 
of foreign body reactions, a large number of animals is needed 
to obtain   sufficient tissue samples for studying the neutrophil 
interaction at various time points.15,16 Second, histological 
sectioning, staining, and tissue image analyses are very labor-
intensive and time-consuming. Finally, these conventional 
methods are cost-prohibitive for carrying out large scale   studies 
required to develop a better understanding of the influence 
of material properties on foreign body reactions. To resolve 
these drawbacks, the overall goal of this investigation was to 
develop a fast, accurate, and simple method to assess neutrophil 
responses to biomaterial implants.
Several imaging methods have been developed to monitor 
the migration of neutrophils. Specifically, 111 indium-labeled 
neutrophils and  99mtechnetium-labeled IL-18BP-Fc-IL-1ra 
(interleukin-18 binding protein-Fc-interleukin-1 receptor 
antagonist) recombinant human fusion protein uptakes have 
been shown to detect neutrophil responses.17 Two-photon 
microscopy and time-lapse imaging have also been used to 
study neutrophil trafficking in the lungs of mechanically ven-
tilated mice.18 Several chemotactic peptide receptor agonists 
have also been investigated for their use in imaging infection 
and associated inflammatory cell accumulation in vivo.19,20 
A leukotriene B4 receptor antagonist, 99mtechnetium-RP517, 
has exhibited a neutrophil targeting ability and has been 
developed for imaging acute myocardium inflammation.21 
Recently, optical imaging systems have been developed to 
target neutrophils. Specifically, studies have shown that the 
peptide cinnamoyl-Phe-(D)Leu-Phe-(D)Leu-Phe (cFLFLF) 
has a high affinity to the formyl peptide receptor (FPR) 
of neutrophils,22 and that near-infrared (NIR)-conjugated 
cFLFLF can be used to detect activated neutrophils in a 
mouse model of ear inflammation.23 However, the high 
hydrophobicity of cFLFLF often leads to a relatively poor 
target-to-background ratio for in vivo imaging.22 To address 
this deficiency, polyethylene glycol (PEG) polymers have 
been used to improve the hydrophilicity of the cFLFLF-NIR 
probes. These improved probes have enhanced efficacy and 
have been used to detect severe neutrophil-associated lung 
inflammation and infection.22–24 However, it is not clear 
whether a similar approach can be used to fabricate imaging 
probes for detecting and quantifying the degree of neutrophil 
recruitment related to medical device-associated foreign body 
reactions in vivo.
To find the answer, FPR-targeting nanoprobes were 
synthesized by crosslinking NIR dye into an eight-arm 
PEG platform. This complex was further conjugated with 
the FPR-targeting peptide, cFLFLF. The efficacy of FPR-
targeting nanoprobes to recognize activated neutrophils was 
first studied in vitro. Using an in vivo imaging system, the 
effectiveness of FPR-targeting nanoprobes in quantifying the 
extent of biomaterial implant-mediated neutrophil recruit-
ment was also assessed. Finally, FPR-targeting nanoprobes 
were also tested for their ability to continuously monitor and 
quantify the extent of the inflammatory response to different 
biomaterial implants and infected catheters in vivo.
Material and methods
Materials
Eight-arm PEG-amine (40,000 molecular weight) was 
obtained from JenKem Technology USA Inc (Allen, TX). 
The peptide, cFLFLF, was custom synthesized by United 
BioSystems Inc (Rockville, MD) and an additional glutamic 
acid was added to the C-terminus of the peptide for permitting 
PEG polymer conjugation (ie, cFLFLF-COOH). Oyster®-800 
TFP Ester was purchased from Boca Scientific Inc (Boca 
Raton, FL). 1-Ethyl-3-(3-(dimethylaminopropyl)carbodi-
imide was purchased from Thermo Scientific Pierce Protein 
Research Products (Rockford, IL). N-hydroxysuccinimide 
and dimethyl sulfoxide were purchased from Sigma-Aldrich 
Corporation (St Louis, MO). All other chemicals were pur-
chased from Sigma-Aldrich.
Preparation and characterization  
of the FPR-targeting nanoprobe
FPR-targeting nanoprobes were prepared by incubating 
  eight-arm PEG-amine (20 mg/1.0 mL phosphate   buffer, 
50 mM, pH 7.4) with Oyster-800 (2.0 mg/1.0 mL   phosphate 
buffer). After incubation at room temperature for 4 hours, 
the eight-arm PEG-Oyster-800 was dialyzed and then 
  lyophilized. The peptide cFLFLF (8.3 mg) was   dissolved 
in 1.0 mL dimethyl sulfoxide in the presence of 4.5 mg 
1-Ethyl-3-(3-(dimethylaminopropyl)carbodiimide and 
4.5 mg N-hydroxysuccinimide to activate the carboxyl group 
(–COOH) at the C-terminus of the peptides.   Following 
overnight incubation at 4°C, the activated peptide solu-
tion was mixed with eight-arm PEG-Oyster-800 solution 
(peptide:eight-arm PEG-Oyster-800 = 27:1 molar ratio). The 
mixtures were incubated at room temperature for 24 hours 
prior to dialysis and lyophilization. The FPR-targeting 
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  nanoprobe   (cFLFLF-PEG-Oyster-800, 1.0 mg/mL) was 
  dissolved in sterilized distilled water and the optical 
property of the nanoprobe was measured using a fluores-
cence spectrometer (RF-5301PC; Shimadzu Corporation, 
Tokyo, Japan), as described previously.25 The peptide to 
dye conjugation ratio was determined using an ultraviolet-
visible spectrometer (Lambda 19 Spectrometer; PerkinElmer, 
Waltham, MA) according to the manufacturer’s instruction 
and a previous publication.26 Briefly, with a known amount 
of nanoprobes, the relative dye and peptide concentrations 
were determined using the spectrometer. Measurements were 
performed at 778 nm and 280 nm wavelengths for the dye and 
peptide, respectively; the extinction coefficient was provided 
by the manufacturer. Values were then compared to a stan-
dard concentration curve. The average value of peptide and 
dye per nanoprobe was calculated by dividing the respective 
concentrations by the total amount of the nanoprobe.
In vitro neutrophil homing  
of the FPR-targeting nanoprobe
To assess the ability of the FPR-targeting nanoprobe to detect 
activated neutrophils, activated mouse neutrophils (9 × 106 
cells/mL) isolated via peritoneal lavage from BALB/c mice 
were used, as described previously.5,27 Various numbers of 
neutrophils were seeded into each well of a 96-well plate prior 
to incubating with either the FPR-targeting nanoprobe or its 
control (PEG-Oyster-800) (40 µL at 0.4 mg/mL) at 37°C for 
30 minutes. At the end of the study, each well was washed 
three times with phosphate buffered saline (50 mM, pH 7.4) 
to remove the unbound nanoprobes. Neutrophil-associated 
fluorescence intensities were then recorded using a microplate 
reader (Infinite® M200; Tecan Group Ltd, Mannedorf, 
Switzerland) at an excitation wavelength of 760 nm and an 
emission wavelength of 830 nm. All the experiments were 
conducted in triplicate. Similar studies were also carried out 
on glass slides for microscopic optical imaging. Following 
nanoprobe incubation, the adherent cells on glass slides were 
also incubated with the fluorescein isothiocyanate-conjugated 
antineutrophil antibody (ab2557; Abcam, Cambridge, MA) 
at 37°C for 30 minutes prior to being washed three times 
with phosphate buffered saline. The adherent cells were then 
observed under an Axiovert® 200 microscope (Carl Zeiss 
MicroImaging, Thornwood, NY) with a Chroma Cy7™ 
filter cube (excitation filter HQ710/75× , dichroic Q750LP 
BS, and emission filter HQ810/90 m; Chroma Technology 
  Corporation, Bellows Falls, VT) and a Zeiss filter set 10 
(excitation filter BP 450–490, dichroic mirror FT 510, and 
emission filter BP 515–565; Carl Zeiss). Cell images were 
captured with a CCD camera (AxioCam MRm), and image 
analysis was performed with AxioVision® 3.1 imaging soft-
ware (Carl Zeiss).
Inflammation and infection animal model
BALB/c mice (female, 20–25 gram body weight) were 
purchased from Taconic Farms Inc (Germantown, NY) and 
were used for all in vivo studies. The animal protocols were 
approved by the University of Texas at Arlington’s Animal 
Care and Use Committee. To induce localized inflammatory 
responses, lipopolysaccharide (LPS; 100 µg/50 µL saline) or 
saline (as control) was injected subcutaneously on the dorsal 
area of mice. Poly(lactic acid) (PLA) microparticles and PEG 
nanoparticles were used as control subjects to trigger vari-
ous extents of foreign body reactions. PLA microparticles 
(5–10 µm in diameter) and PEG nanoparticles (100 nm in 
diameter) were synthesized as previously demonstrated.28,29 
As recently described, 100 µL of the particles or saline (as 
control) were injected into the subcutaneous space.25 Limited 
experiments were also carried out using neutrophil-depleted 
mice. Neutrophil depletion was performed based on a pub-
lished protocol.30 In brief, animals were injected intraperi-
toneally with 100 µL of neutrophil neutralizing antibody 
(rabbit anti-mouse neutrophil antibody; Accurate Chemical 
and Scientific Corporation, Westbury, NY) at 18 hours and 
additionally at 1 hour prior to the experiments. To study 
indwelling catheter-associated inflammatory responses 
and infection, polyurethane (PU) catheters (1 cm in length) 
obtained from Sentry Medical Products (Green Bay, WI) were 
incubated with saline or luciferase-transgene   Staphylococcus 
aureus Xen29 strain (1.6 × 108 colony-forming units/mL; 
Caliper Life Sciences, Hopkinton, MA) at 37°C for 3 hours 
and then implanted subcutaneously in mice following an 
established protocol.31–33 After the implantation of particles, 
saline, or catheters for 24 hours, animals were intravenously 
administered with 60 µL of the FPR-targeting nanoprobe 
(0.4 mg/mL) 3 hours prior to imaging analyses.
Imaging analyses of the whole  
body and harvested organs
The whole body fluorescence images were taken using the 
In-Vivo FX Pro system (f-stop: 2.5, excitation filter: 760 nm, 
emission filter: 830 nm, 4 × 4 binning; Carestream Health, 
Rochester, NY). For imaging analyses, regions of interest 
were drawn over the implantation locations in the fluores-
cence images, and the mean intensities for all pixels in the 
regions of interest were calculated. All data analyses were 
performed with the Carestream Molecular Imaging   Software, 
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Network Edition 4.5 (Carestream Health). To assess the 
biodistribution of FPR-targeting nanoprobes in vivo, ani-
mals were sacrificed and tissues were rapidly dissected. The 
isolated organs/tissues were then immediately imaged using 
the In-Vivo FX Pro system.
Histological analysis of localized 
inflammatory responses
To assess the extent of neutrophil responses in various 
models, the implants and surrounding tissue were isolated 
for histological evaluation as described earlier.34,35 Hema-
toxylin and eosin staining was performed on all samples 
to assess the overall inflammatory reactions. To quantify 
the number of recruited neutrophils, some tissue sections 
were immunohistochemically stained with pan-neutrophil 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 
and then with peroxidase-conjugated goat anti-rat second-
ary antibodies (Jackson ImmunoResearch Laboratories, 
West Grove, PA). All histological imaging analyses were 
performed on a Leica microscope (Leica Microsystems 
GmbH, Wetzlar, Germany) and processed using NIH 
ImageJ (National Institutes of Health, Bethesda, MD).34 
To visualize the distribution of the FPR-targeting nanoprobe 
in inflamed tissues, fresh tissue sections were also imaged 
using an Axiovert 200 microscope with an NIR filter cube 
as described previously.25
Statistical analysis
The statistical comparison between different treatment groups 
was carried out using Student’s t-test. Differences were con-
sidered statistically significant when P # 0.05.   Linear regres-
sion analyses and the correlation coefficient were calculated 
to reflect the relationship between fluorescence intensities 
and neutrophil numbers in vitro and in vivo.
Results
Characterization of the FPR-targeting 
nanoprobe
PEG has been widely used as a polymeric carrier in polymer-
based drug delivery and as an imaging probe due to its low 
toxicity, low nonspecific binding, and prolonged blood circu-
lation time.36 In this study, the FPR-targeting nanoprobe was 
prepared by sequentially conjugating NIR dye and the peptide 
cFLFLF into an amino-terminated eight-arm PEG platform 
through 1-Ethyl-3-(3-(dimethylaminopropyl)carbodiimide 
coupling chemistry (Figure 1A).37,38 Ultraviolet-visible 
spectrometer measurements show that unlike the control 
probes FPR-targeting nanoprobes have an absorbance peak 
at 280 nm, identical to the peak absorbance wavelength of 
the peptide (Figure 1B). These results support the conclu-
sion of successful conjugation of peptide ligands to FPR-
targeting nanoprobes. On average, each mole of nanoprobe 
was found to contain 1.8 moles of dye and 6.0 moles of 
peptide.   Furthermore, fluorescence spectroscopic results 
demonstrated that the conjugation of NIR dye did not sig-
nificantly alter the fluorescence spectra of free Oyster-800 
dye with a maximum emission at 799 nm and excited at 
785 nm (Figure 1C).
FPR-targeting nanoprobes recognize 
activated neutrophils in vitro
To examine their ability to recognize activated neutrophils 
in vitro, FPR-targeting nanoprobes (NIR-PEG-cFLFLF) 
or control probes (NIR-PEG) were incubated with mouse 
neutrophils. The cells were also stained with a rat anti-
mouse monoclonal neutrophil antibody and a fluorescein 
isothiocyanate-conjugated goat anti-rat secondary antibody 
for neutrophil confirmation. The cells were then observed 
using an optical microscope. As anticipated, it was found that 
only activated neutrophils (stained with the antibody, green 
color) were associated with the FPR-targeting nanoprobe 
(red color) (Figure 1D). This finding supports the hypothesis 
that FPR-targeting nanoprobes may be used to specifically 
identify activated neutrophils. To further study whether the 
nanoprobes can be used to quantify the number of activated 
neutrophils in vitro, various concentrations of neutrophils 
were incubated with the probes and the neutrophil-associated 
fluorescence intensities were determined. In support of the 
hypothesis, it was found that there was a linear correla-
tion between the fluorescence intensity and the number of 
neutrophils (Figure 1E). In contrast, the fluorescence inten-
sity of neutrophils incubated with the control nanoprobes 
(NIR-PEG) remained close to the background intensity 
regardless of the cell number. Overall, the in vitro results 
support that FPR-targeting nanoprobes can preferentially 
bind to neutrophils and may be used to quantify the number 
of neutrophils in vitro.
Detection of LPS-induced localized 
neutrophil responses using  
FPR-targeting nanoprobes
The effectiveness of FPR-targeting nanoprobes for detecting 
neutrophil accumulation in inflamed tissue was first tested 
in vivo using an LPS-induced inflammatory model. After LPS 
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subcutaneous administration for 24 hours, the FPR-targeting 
nanoprobe was injected intravenously and whole body 
images were recorded at different time points (Figure 2A). 
A substantial increase in fluorescence intensity was found 
at the LPS injection site, in as short as 30 minutes   following 
nanoprobe injection, in comparison to the control. The 
preferential accumulation of the FPR-targeting nanoprobe 
at the LPS site increased with time and reached its plateau 
at 2–3 hours, where the LPS treatment triggered 8.6 times 
higher fluorescence intensity than the control. To determine 
the biodistribution of the nanoprobes, the fluorescence 
images of the isolated organs or tissues were recorded and 
used to quantify the organ/tissue-associated fluorescence 
intensities (Figure 2B). As anticipated, large quantities of the 
FPR-targeting nanoprobe were found in the liver and kidney. 
A substantial amount of fluorescence from the nanoprobes 
was also found in the lung, heart, and pancreas. In agreement 
with the whole body imaging results, it was found that the 
average fluorescence intensity at the LPS injection sites was 
4.5 times higher than the control tissues (saline injection) 
(Figure 2B). Based on the in vitro results, the authors believe 
that the accumulation of FPR-targeting nanoprobes at the LPS 
injection site is likely associated with the accumulation of 
neutrophils in the tissue. Indeed, using hematoxylin and eosin 
staining and immunohistochemical staining, it was found 
that the LPS injection triggered an increase in inflammatory 
cells (ten times higher) and neutrophils (90 times higher) in 
comparison to the control tissue (Figure 2C).
Use of FPR-targeting nanoprobes  
to assess neutrophil accumulation  
near PLA implants
The results thus far support that the FPR-targeting nanoprobes 
can detect LPS-elicited severe inflammatory responses. It is 
not clear, however, whether the FPR-targeting nanoprobes 
can also determine mild or localized inflammatory responses, 
such as foreign body reactions and associated neutrophil 
reactions. To find the answer, mice were subcutaneously 
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implanted with PLA microparticles for 24 hours to trigger   
foreign body reactions. The animals were subsequently admin-
istered intravenously with the FPR-targeting nanoprobes. As 
expected, PLA microparticle implantation triggered foreign 
body reactions which were accompanied by a large number 
of inflammatory cells and neutrophils (Figure 3A and B). The 
recruited neutrophils most likely play an essential role in the 
pathogenesis of the foreign body reactions. This is clearly 
observed through neutrophil depletion studies which show 
a substantial reduction in the extent of inflammatory cell 
(∼50%) and neutrophil (∼75%) recruitment to PLA implant 
sites when compared with controls (Figure 3A and B). To 
validate that the nanoprobe accumulation is primarily due to 
the infiltration of neutrophils, both control and neutrophil-
depleted animals were subcutaneously implanted with PLA 
particles and then intravenously administered with the 
FPR-targeting nanoprobes. As expected, neutrophil deple-
tion resulted in decreased fluorescence intensity from the 
PLA implant site at 1 hour (∼100% intensity reduction) 
and 4 hours (82% intensity reduction) in comparison to the 
control animals (Figure 3C). These findings demonstrate the 
high efficiency of FPR-targeting nanoprobes in recognizing 
and targeting activated neutrophils at the inflamed sites. 
Furthermore, it is likely that the nanoprobe can be used 
to detect implant-associated neutrophil accumulation and 
  foreign body reactions.
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Quantify the degree of foreign body 
reactions using FPR-targeting nanoprobes
It is well established that biomaterial implants trigger vari-
ous extents of neutrophil responses. Additionally, there is 
a good relationship between neutrophil recruitment and 
biomaterial-mediated acute inflammatory responses.4,5 It 
may therefore be possible to use FPR-targeting nanoprobes 
to assess the extent of foreign body reactions and biomate-
rial tissue compatibility. To test this hypothesis, PLA and 
PEG particles were selected as model biomaterials.   Previous 
studies have shown that PLA and PEG particles prompt 
mild and weak inflammatory responses, respectively.25,39 
The particles were subcutaneously implanted in mice, with 
saline as a control, for 24 hours prior to administration of the 
imaging nanoprobe. Three hours after the probe injection, 
whole body imaging was performed. The results show that 
the fluorescence signal at the PLA and PEG implantation sites 
were much higher than at the control saline site (Figure 4A). 
Quantitative analysis shows that PLA and PEG trigger 9.5 
and 2.8 times higher fluorescence intensity than the control, 
respectively. To determine the distribution of the nanoprobes 
within the implantation sites, tissue sections of the PLA and 
PEG implants were observed under a fluorescence micro-
scope (Figure 4B). It was found that a high concentration 
of nanoprobes was present in tissue neighboring the PLA 
implants, while significantly lower amounts were detected 
surrounding the PEG implants. Histological analysis shows 
that PLA particles prompted a greater extent of neutrophil 
accumulation at the implant site than PEG implants, while 
negligible neutrophils populated the control site (Figure 4C). 
Quantitative analysis reveals that 2.5 times more neutrophils 
accumulated around the PLA particles than the PEG par-
ticles (Figure 4D). A comparison and correlation between 
fluorescence intensity and neutrophil counts was further 
performed to determine a potential relationship between the 
nanoprobe accumulation and implant-mediated neutrophil 
responses. The results show a near linear trend (correlation 
coefficient = 0.89) (Figure 4E). These findings confirm that 
FPR-targeting nanoprobes can be employed as an effective 
imaging probe not only to mark the inflammation location but 
also to estimate the extent of biomaterial-mediated neutrophil 
infiltration and inflammatory responses in vivo.
Detection of infected catheters  
by means of FPR-targeting nanoprobes
Given the ability of the nanoprobe to preferentially target 
neutrophils associated with particle implants in vivo, it was 
further investigated whether the nanoprobe could be used to 
detect inflammatory responses elicited by bacteria-colonized 
medical devices. For that, PU catheters were used as a model 
medical device. Some of the PU catheters were inoculated 
with the luciferase transgenic S. aureus for 24 hours prior to 
subcutaneous implantation. The FPR-targeting nanoprobes 
were then intravenously administered and images were cap-
tured 3 hours after the nanoprobe injection. Strong biolumi-
nescent signals from the infected catheters were found, but 
not from the control catheters, demonstrating the colonization 
of bacteria on PU catheters in vivo (Figure 5A). In addition, 
bright fluorescence signals were found at the area of the 
infected catheters (Figure 5B). Analysis and   quantification 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2063
Formyl peptide receptor-targeting NIR nanoprobeInternational Journal of Nanomedicine 2012:7
750
0
A
B
DE
C
2004 00 6008 00
PLA
Saline
PLA
PLA
PEG
Skin
Skin
PEG
N
e
n
t
r
o
p
h
i
l
 
c
o
n
n
t
/
v
i
s
i
o
n
N
e
n
t
r
o
p
h
i
l
 
n
u
m
b
e
r
/
v
i
s
i
o
n
PEG Saline
200
100
0
200
PLA
PEG
Saline
R2 = 0.89
***
***
**
** **
**
100
0 350 700
0
250
500
0
PLA PEG
H&E
P
L
A
F
l
u
o
r
e
s
c
e
n
c
e
 
i
n
t
e
n
s
i
t
y
 
(
A
U
)
PEG
P
L
A
PEG
Saline
Neutrophil IHC 
Fluorescence intensity (AU) 
Saline
Figure 4 In a foreign body response animal model, poly(lactic acid) particles, polyethylene glycol particles, and saline were implanted subcutaneously in the back of animals 
for 24 hours prior to formyl peptide receptor-targeting probe injection. The animal images were taken 3 hours after probe administration. (A) Representative in vivo 
fluorescence imaging (left) and quantitative analysis (right) of the fluorescence intensity at different implantation sites (poly[lactic acid], polyethylene glycol, and saline). (B) 
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of the fluorescence signal shows 8.8 times higher nanoprobe 
accumulation near the infected catheters versus the controls 
(Figure 5B). Further analysis was performed on tissue 
sections confirming a substantial increase in nanoprobe 
concentration in tissue surrounding the infected PU catheter 
in comparison to the controls (sterile PU catheter implants) 
(Figure 5C). Furthermore, histological analysis confirmed 
that the neutrophil population surrounding the infected tissue 
was 7.3 times higher than the tissue surrounding the control 
PU catheters (Figure 5D and E). These results suggest that 
FPR-targeting nanoprobes can be used to monitor neutrophil 
responses to catheter implants. In addition, the nanoprobe is 
able to distinguish infected catheters versus sterile catheters, 
based on the extent of neutrophil responses.
Discussion
The development of imaging nanoprobes is essential to 
monitoring foreign body reactions. In the current study, the 
peptide cFLFLF was selected as a targeting ligand based 
on the following advantages. First, several recent studies 
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have shown that cFLFLF has a high binding affinity to the 
neutrophils’ FPR.22,23 In addition, cFLFLF possesses antago-
nistic properties and does not induce neutropenia like other 
high-affinity chemotactic peptide analogs, such as formyl-
methionyl-leucyl-phenylalanine peptide.22,23 In the current 
study, a FPR-targeting (cFLFLF-conjugated) nanoprobe was 
fabricated using an eight-arm PEG core as a multifunctional 
platform. The eight-arm PEG core was chosen for several 
reasons. First, the multifunctional platform allowed opti-
mization of the peptide density in a single nanoprobe, thus 
enhancing its targeting efficiency.26,40 Second, the modifica-
tion of the peptide by PEGylation may enhance nanoprobe 
hydrophilicity, reduce nonspecific binding, and thus improve 
bioavailability and clearance when used in vivo.41,42 For in 
vivo imaging, Oyster-800 dye was chosen for its biocompat-
ibility and high wavelength (∼800 nm) and because it has 
minimal tissue absorbance and background with improved 
fluorescence sensitivity.43,44
The in vitro experiments demonstrate that the FPR-
  targeting nanoprobe has high affinity and can specifically 
bind to neutrophils. These results concur with previous 
reports from microscopy studies of other fluorescently-
labeled chemotactic peptides.22,45–47 By establishing a linear 
correlation between the fluorescence intensity and the 
neutrophil concentration, it was demonstrated that the nano-
probe may have some potential for quantitative analysis of 
neutrophils in vivo.25
Subcutaneous injection of LPS is a well-established 
inflammation model prompting severe inflammatory 
responses, accompanied by the recruitment of neutrophils, 
macrophages/monocytes, and other immune cells.48,49 Indeed, 
immediately following intravenous injection, FPR-targeting 
nanoprobes accumulated in the area of LPS-induced inflam-
mation, which is consistent with previous findings that used 
a phorbol myristate acetate-induced acute inflammation 
model.23 Additionally, the substantial reduction of nanoprobe 
accumulation in neutrophil-depleted mice further supports 
the fact that the nanoprobe targets neutrophil recruitment 
and accumulation at the inflamed sites. Furthermore, the 
results show that FPR-targeting nanoprobes may also be 
used to detect mild inflammatory responses, such as foreign 
body reactions.
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The  mechanism  of  FPR-targeting  nanoprobe 
accumulation at the inflamed tissue is not entirely understood. 
The results suggest that the buildup of the FPR-targeting 
nanoprobe was likely caused by their interactions with FPR 
on the surfaces of activated neutrophils. This is supported 
by observations of the fluorescence intensity being reduced 
by approximately 82% following neutrophil depletion. The 
residual fluorescence intensity at the implantation site in 
neutrophil-depleted animals may be caused by the following 
reasons. First, neutrophil depletion can only reduce ∼80% 
of neutrophils from circulation,50 and a small number of 
residual neutrophils was still found to accumulate at the 
implant sites. Second, it is well established that biomaterial 
implants prompt histaminic reactions.51,52 Also, an “enhanced 
permeability and retention” effect at the implantation site 
due to leaky blood vessels may permit the permeation of 
a small amount of the imaging nanoprobes to the tissue 
surrounding implants.25,53
The ability of the FPR-targeting nanoprobe to detect and 
quantify foreign body reactions was tested using different 
materials. By implanting various polymeric particles, it has 
been confirmed that the FPR-targeting nanoprobe can be used 
to image and to assess the extent of neutrophil responses 
to different particle implants. Interestingly, optical imag-
ing shows that the majority of the nanoprobes accumulate 
inside or in the tissue surrounding particle implants. Equally 
importantly, there is a good relationship between the extent 
of FPR-targeting nanoprobe fluorescence and the number of 
recruited neutrophils at the implant site. These results dem-
onstrate that the FPR-targeting nanoprobes can be used not 
only to detect severe inflammation as reported earlier,19,22 but 
also to estimate the extent of the inflammatory response to 
biomaterials. Using an infected catheter implantation model, 
it was found that the bacteria-infected catheters significantly 
enhanced the localized accumulation of FPR-targeting nano-
probes in comparison to controls. Coincidentally, a large 
number of neutrophils were present nearby the infected cath-
eter surface, which is in agreement with previous findings.54 
Overall, the data supports the hypothesis that FPR-targeting 
nanoprobes may be used to detect neutrophil responses in 
the event of foreign body reactions and device-centered 
infection in vivo.
This study demonstrates that FPR-targeting nanoprobes 
can be fabricated to specifically detect activated neutrophils. 
Since neutrophils represent a major subset of inflammatory 
cells, and neutrophil interactions play an important role in 
the acute inflammatory response, it is anticipated that FPR-
targeting nanoprobes may be a powerful tool to monitor 
the in vivo inflammatory response. Equally important, the 
  FPR-targeting nanoprobe-based in vivo fluorescence imaging 
can provide an alternative method for analyzing a biomate-
rial’s tissue compatibility in a rapid, noninvasive, and real-
time manner. This would greatly improve the understanding 
of the processes and factors governing foreign body responses 
to biomaterials while reducing the number of animals needed 
to carry out extensive in vivo testing. It is worthwhile noting 
that the short tissue penetration depth of the fluorescence 
signal will limit the imaging modality’s application in clinical 
practice. The inherent drawback, however, may be overcome 
through combinations of different imaging modalities such 
as positron emission tomography and magnetic resonance 
imaging in which the imaging nanoprobes could be conju-
gated to radionucleotides. Overall, the authors believe that the 
inflammatory cell-targeting imaging technique has a practical 
application in the evaluation and diagnosis of implant safety 
and performance.
Conclusion
Taking advantage of the high affinity of peptide cFLFLF 
to neutrophils’ FPR, an FPR-targeting NIR nanoprobe was 
developed to detect activated neutrophils. The nanoprobes 
were found to have a high affinity and specificity for neutro-
phils in vitro as well as in vivo, with the ability to detect and 
quantify the degree of LPS-induced inflammatory responses 
and foreign body reactions. Further studies uncovered that the 
FPR-targeting nanoprobe can be used to distinguish sterile 
versus infected catheters. These results demonstrate that 
the FPR-targeting nanoprobe may be used as an effective, 
noninvasive, in vivo imaging tool for real-time evaluation 
of biomaterial safety and tissue compatibility.
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